
[Cancer Research 60, 156-163, January 1, 2000]
© 2000 American Association for Cancer Research
p21WAF1 Regulates Anchorage-independent Growth of HCT116 Colon Carcinoma Cells via E-Cadherin Expression1
Sebastian Mueller,
Enrique Cadenas and
Axel H. Schönthal2
Department of Internal Medicine IV, University of Heidelberg, 69115 Heidelberg, Germany [S. M.], and Department of Molecular Pharmacology and Toxicology, School of Pharmacy [E. C., S. M.], Department of Molecular Microbiology and Immunology, School of Medicine, and K. Norris Jr. Comprehensive Cancer Center [A. H. S.], University of Southern California, Los Angeles, California 90033
 |
ABSTRACT
|
|---|
The cyclin-dependent kinase inhibitor p21WAF1 has been
characterized as an important effector of the tumor suppressor p53 and
has been linked to various growth-regulatory processes. To identify a
potential role of p21 in anchorage-dependent growth control, we
analyzed a pair of HCT116 human colon carcinoma cell lines that
differed only in their p21 status. We found that during suspension
culture, HCT116 cells (which contain wild-type p53 and p21) continued
to proliferate and formed compact multicellular spheroids (MCSs). In
contrast, HCT116 cells engineered to lack functional p21 (HCTp21-/-)
were unable to form MCSs in suspension culture, ceased proliferation,
and eventually died through apoptosis. The parental HCT116 cells
underwent the same fate when treated with hyaluronidase, indicating
that cell-cell contact might be required for survival in suspension
culture. We established that E-cadherin was induced in HCT116 but not
in HCTp21-/- cells and accounted for the formation of MCSs. Forced
expression of E-cadherin or p21 in HCTp21-/- cells restored the
ability to form MCSs and to grow independently of anchorage. Moreover,
HCTp21-/- cells exhibited a severely reduced transformed phenotype
and demonstrated greatly enhanced chemosensitivity in suspension
culture. Thus, our results link an important regulator of the cell
cycle machinery to the expression of a cell-cell adhesion molecule
involved in tumor formation. Because our results indicate that loss of
p21 severely impairs the ability of HCT cells to grow independently of
anchorage, it may not be coincidental that inactivating mutations of
this gene are very rarely found in tumor cells.
 |
INTRODUCTION
|
|---|
Cell cycle checkpoints play crucial roles in maintaining tissue
homeostasis, and loss of these control mechanisms may contribute to the
development of the malignant phenotype. The
CKI3
p21WAF1 has been characterized as an important
component of these events and was found to be a crucial executioner of
p53-induced cell cycle arrest (1, 2, 3)
. It has been shown in
many examples that activation of p53 in response to various external
insults that threaten the integrity of the cell leads to the increased
expression of p21 (1
, 4, 5, 6, 7)
. Elevated levels of p21, in
turn, bind to and inhibit the activity of CDKs and proliferating cell
nuclear antigen, both of which are essential for cell cycle progression
(8, 9, 10)
. As a consequence, cellular proliferation is
halted, and the cells are arrested in the cell cycle.
To further determine the exact contribution of p21 to cell-regulatory
events, cell lines without the p21 gene were
established and investigated. In such studies, it was found that
p21-negative mouse fibroblasts exhibit a partial deficiency in
G1 cell cycle arrest after radiation or
nucleotide depletion (11
, 12)
. In human HCT116 colon
carcinoma cells engineered to lack both copies of the p21
gene, a complete loss of G1 cell cycle arrest
became evident, and this was associated with a predisposition to S- and
M-phase uncoupling after exposure to DNA-damaging drugs
(13)
. Furthermore, an altered sensitivity of these
p21-negative HCT116 cells to certain DNA-damaging chemotherapeutic
drugs has been demonstrated both in vitro and in
vivo (7
, 13, 14, 15, 16)
. In addition, p21-negative cells
have been shown to be defective in nucleotide excision repair, and it
has been suggested that this may underlie their increased sensitivity
to certain chemotherapeutic drugs (16)
. However, despite
the demonstrated role of p21 as a cell cycle inhibitor, inactivating
mutations of this gene are very rarely found in tumor cells (17
, 18)
, and mice lacking the p21 gene do not exhibit an
increased rate of spontaneous tumors (11)
. Therefore, the
potential role of p21 in tumor development has remained largely
unclear.
The in vitro culture of cells in suspension, where cells are
allowed to form three-dimensional MCSs, is believed to more closely
mimic in vivo conditions than the culture of cells in
two-dimensional monolayers (19)
. However, except for some
hematopoietic cells, normal cells do not proliferate in suspension
culture, a phenomenon called anchorage dependence. In contrast, tumor
cells are able to continue to grow in suspension culture (or embedded
in soft agar), and this anchorage-independent phenotype has been found
to closely correlate with their ability to form tumors in animals
(20
, 21) . In general, the growth rate in suspension
culture varies greatly between different tumor cell lines
(22)
, which may indicate the function of cell
type-specific processes modulating anchorage-independent growth. In
this regard, it was shown in one study (23)
that
intercellular adhesions mediated by the cell surface receptor
E-cadherin were required for the survival and anchorage-independent
growth of human HSC-3 oral squamous carcinoma cells. In contrast,
another study (24)
described that transfected E-cadherin
resulted in the suppression of anchorage-independent growth of EMT/6
mouse mammary carcinoma cells. Although the underlying basis for this
discrepancy is unclear, the detailed analysis of E-cadherin in these
processes is of importance because this molecule not only plays a
crucial role in normal tissue morphogenesis and organization (25
, 26)
but presumably also in invasive processes and the metastatic
spread of tumor cells (27, 28, 29, 30)
.
The contribution of CKIs to anchorage-dependent growth control has been
recognized as well. After transfer of monolayer cells to suspension
culture, the expression of several CKIs, such as
p21WAF1, p27KIP1,
p16INK4a, or p18INK4c, has
been found elevated and implicated in the subsequent growth arrest of
anchorage-dependent cells (22
, 31, 32, 33, 34, 35, 36)
. Curiously, a very
similar induction of p21 and p27 has also been detected in many
anchorage-independent tumor cells (22
, 33)
. It appears
that in this latter case, the CKIs are sequestered in the cytoplasm and
therefore prevented from exerting their inhibitory effect in the
nucleus (33)
. However, this neutralizing mechanism seems
only partially effective because most, if not all, tumor cells in
suspension exhibit reduced proliferation rates when compared with
monolayer culture (22)
. In addition, there are striking
cell type-specific differences; in a review of 39 different tumor cell
lines, only 22 were found to exhibit increased expression of either
p16, p21, or p27 after transfer to suspension culture conditions
(22)
.
In an attempt to further explore the role of p21 in
anchorage-independent growth, we comparatively analyzed the HCT116
human colon carcinoma cell line and derivatives thereof that were
engineered previously (37)
to lack both alleles of the
p21 gene (HCTp21-/-). Here, we show that HCTp21-/- cells
have lost the ability to grow independently of anchorage and die
through apoptosis when transferred to suspension culture. This
phenotype is attributable to the loss of induction of E-cadherin and
insufficient cell-cell adhesion after detachment and can be overcome by
transfection with either p21 or E-cadherin expression vectors.
Moreover, HCTp21-/- cells exhibit severely reduced capacity for tumor
formation in chicken embryos and are unable to form foci in monolayer
culture. In addition, the absence of tight cell-cell interactions
potentiates the sensitivity of these cells toward chemotherapeutic
agents when assessed in suspension culture. Thus, our study links a
major regulator of the cell cycle to the expression of a cell-cell
adhesion molecule with implications for the tumorigenic potential and
chemosensitivity of these cells. It further indicates that p21 is
required for anchorage-independent growth, and tumorigenic potential,
of HCT116 colon carcinoma cells.
 |
MATERIALS AND METHODS
|
|---|
Cell Culture.
HCT116 and the corresponding HCTp21-/- cells were kindly provided by
B. Vogelstein (Johns Hopkins, Baltimore, MD) and cultured as described
previously (37)
. For suspension cultures, tissue culture
dishes or 96-well plates were coated with poly-HEMA (Sigma). For the
disruption of cell-matrix interactions, cells grown as a monolayer were
trypsinized, dispersed by pipetting, and seeded onto poly-HEMA-coated
dishes.
Soft Agar Assays.
Assays were performed as described previously (38)
with
104 cells/well in a six-well plate.
Immunoblotting.
Immunoblotting was performed as described previously (35)
.
Monoclonal and polyclonal antibodies against E-cadherin were obtained
from Santa Cruz Biotechnology, Zymed, and ICN/Cappel. Antibodies
against p21 and polyclonal antibodies against P-cadherin and N-cadherin
were purchased from Santa Cruz Biotechnology. Anti-integrin antibodies
were a gift from P. C. Brooks (University of Southern California, Los
Angeles, CA).
Stable Transfection.
Human E-cadherin cDNA (39)
and p21 cDNA (40)
were stably transfected into HCTp21-/- cells using the vector
pcDNA6/V5-His (Invitrogen), which placed the gene under the control of
the CMV promoter. Stably transfected cells were selected with the
antibiotic blasticidin (Invitrogen).
Cell Cycle Analysis.
Cells from monolayer or suspension culture were harvested by
trypsinization and treated with 10 mg/ml hyaluronidase for 15 min at
37°C to disrupt cell-cell adhesions. Cells were then fixed in 90%
ethanol, treated with 40 µg/ml RNase A, stained with 20 µg/ml
propidium iodide, and analyzed by flow cytometry on a FACScan analyzer
(Becton Dickinson).
Oligonucleotide Treatment.
Synthetic phosphorothioate-modified oligonucleotides were provided by
the Core Facility of the K. Norris Jr. Comprehensive Cancer Center. The
sequences of anti-p21 oligonucleotides AS-MID and AS-IC, as well the
control oligonucleotides 18 MER and 21 MER, have been published
elsewhere and shown to be effective at inhibiting p21 expression
(41)
. The cytofectin GS2888 (Ref. 42
; a gift
from W. M. Flanagan, Gilead Sciences, Foster City, CA) was used for
transfection. One µM oligonucleotide was incubated with
105 cells/ml 24 h before detachment and
again immediately after detachment.
Cytotoxicity and Proliferation Assays.
Cell number and cytotoxicity were determined using an assay kit that is
based on the cellular conversion of a tetrazolium salt (MTT) into a
blue formazan product that is detected using a 96-well plate reader at
570 nm. The kit was obtained from Boehringer Mannheim and used
according to the manufacturers instructions.
TUNEL Assay.
To measure apoptotic cell death, cells were labeled with FITC, and
104 cells/point were analyzed with the use of
FACStar (Becton Dickinson). In addition, cell death was confirmed by
preparing cryosections of MCSs and staining of cells in
situ. For this purpose, MCSs of cells cultured in suspension for
48 h were collected, embedded in Tissue-Tek (Sakura), and frozen
on dry ice. Cryosections were air dried and fixed in 3% formalin.
TUNEL reaction (43)
was performed using a kit according to
manufacturers instructions (Boehringer Mannheim). After staining,
samples were processed for examination with a Nikon fluorescence
microscope using filters for FITC.
Annexin V Assay.
Externalized phosphatidylserine was detected by analyzing the binding
of FITC-labeled annexin V (44)
with the use of a
commercially available kit (Calbiochem). Cells were costained with
propidium iodide and analyzed by flow cytometry for necrosis and
apoptosis.
E-Cadherin Blocking Antibody.
Cells were seeded at a density of 105 cells/ml in
96-well plates in the presence of mouse anti-human E-cadherin
monoclonal antibody (clone SHE78-7; Zymed Laboratories) at 1 µg/ml
and incubated for up to 72 h. A mouse anti-p53 monoclonal antibody
added to monolayer and suspension cultures at up to 10 µg/ml was used
as control.
Chicken Embryo Tumorigenicity Assay.
The assay was performed as reported previously (45)
with
the following modifications. Tumor cells at a density of
106 cells/40 µl were transferred onto the
chorioallantoic membrane of 10-day-old chicken embryos. The eggs were
further incubated for 7 days, and the tumors were harvested. Tumor
volume (V) was calculated using the formula
V = d2
D/2, where d is the smallest tumor diameter and
D is the largest diameter (in millimeters).
Adhesion Assays.
Adhesion assays were performed according to procedures described
recently (46)
with some modification as follows. HCTp21 or
HCTp21-/- cells (4 x 104) were
seeded onto 96-well microplates coated with different ECM proteins. The
wells had been coated with up to 50 µl of ECM protein solution until
evaporation had finished with the following concentrations: 25 µg/ml
vitronectin in PBS, 25 µg/ml fibronectin in PBS, 25 µg/ml laminin
in PBS, 0.1 mg/ml collagen in 0.2 N acetic acid, and 200
µg/ml BSA in serum-free medium. After coating, all wells were rinsed
three times with serum-free medium containing 200 µg/ml BSA. The
cells were allowed to adhere for 1530 min (depending on the ECM
protein) in a 5% CO2 incubator. Incubation time
was stopped as soon as cells started to adhere. The wells were then
washed three times with serum-free medium to remove unattached cells.
Cell number was determined using the MTT assay as described above.
 |
RESULTS
|
|---|
HCTp21-/- Cells Do Not Form Compact MCSs.
Our experiments were done with the human colon carcinoma cell line
HCT116 and two independent isogenic derivatives thereof that lacked
both alleles of the p21 gene, called HCTp21-/-. These cell
lines were characterized previously and exhibited identical morphology,
growth rates, and cell cycle distribution under monolayer cell culture
conditions (37)
. They are near-diploid and harbor
wild-type p53. To study their proliferation and morphology under
anchorage-independent conditions, we transferred these cells from
monolayer to suspension culture. Surprisingly, under these conditions,
the cells exhibited obvious morphological differences. HCT116 cells
formed tight, densely packed MCSs where single cells could not be
discriminated. In contrast, HCTp21-/- cells aggregated only very
loosely with fewer, easily discernible cells (Fig. 1)
.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 1. Spheroid formation of HCT cells in suspension. HCT116 and
HCTp21-/- cells grown as a monolayer were trypsinized and transferred
to HEMA-coated plates at 104 cells/ml. After 48 h of
culture in suspension, cells were photographed at x40. Depicted are
HCT116 cells (left), which form dense spheroids, and
HCTp21-/- cells (right), which adhere to each other only
very weakly. Representative sections of each culture were selected.
|
|
HCTp21-/- Cease Proliferation in Suspension Culture and
Eventually Die through Apoptosis.
When the proliferation of these cells was measured, there was a smaller
increase in cell number for the HCTp21-/- cells within the first
48 h of suspension culture, and their proliferation ceased
thereafter (Fig. 2A)
. FACS analysis indicated that the slower growth of
HCTp21-/- cells was not attributable to cell cycle blockage, because
the percentage of these cells in S phase was 34% as compared with 20%
for the HCT116 cells (Fig. 3A)
. This is in agreement with earlier observations that
HCTp21-/- cells have a reduced ability to arrest in
G1 of the cell cycle (13)
.

View larger version (93K):
[in this window]
[in a new window]
|
Fig. 2. Proliferation and cell-cell contact of HCT cells in
suspension. HCT116 and HCTp21-/- cells were transferred from
monolayer to suspension culture. In A, the proliferation
of cells in the absence (-HR) or presence
(+HR) of 2 mg/ml hyaluronidase was measured at the
indicated times using the MTT assay. We confirmed that the absorbance
at 570 nm linearly corresponded to the number of living cells.
Bars, SD. B, representative
sections of suspension cultures treated with 2 mg/ml hyaluronidase for
48 h and stained with MTT to visualize live cells. Right
panel, HCTp21-/- cells; Left panel, HCT116 cells.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3. Cell cycle distribution and apoptosis of suspension cells.
HCT116 and HCTp21-/- cells were transferred from monolayer to
suspension culture. In A, the cells were harvested after
48 h, and FACS analysis was performed in comparison with cells
grown as monolayer. Each column represents the
respective percentage distribution of cells in G1, S, or
G2-M (G2) as the average from three
measurements; bars, SD. In B, the cells
were harvested at various time points for the analysis of apoptotic
cell death. Cell death was determined by TUNEL assay as described in
"Materials and Methods."
|
|
Because previous observations have indicated that under certain
conditions HCTp21-/- cells are more prone to undergo apoptosis
(13)
, we investigated this aspect. When cells in
suspension culture were stained with the tetrazolium salt MTT, cell
death became obvious in cultures of HCTp21-/- cells (not shown).
Morphological changes of these cells included shrinkage and rounding,
and the condensed, fragmented nuclei were stained intensely by TUNEL
(Fig. 3B)
. Greatly increased apoptotic cell death of
HCTp21-/- cells as compared with HCT116 cells became obvious at
48 h after detachment and increased further over the course of
several days. At day 7, more than half of the whole population of
HCTp21-/- cells were apoptotic, whereas only 12% of HCT116 cells
stained positively (Fig. 3B)
. Apoptosis as the main cause of
cell death in HCTp21-/- cells was further confirmed with the use of
the FITC-labeled annexin V, which binds to phosphatidylserine of
apoptotic cells (not shown), as well as by in situ TUNEL
staining of cryosections from MCS of each cell type (not shown).
Cell-Cell Adhesion Is Crucial for the Survival of HCT Cells in
Suspension Culture.
To investigate whether the pronounced differences in MCS formation were
involved in the induction of apoptosis, we used the enzyme
hyaluronidase to break and prevent cell-cell interactions
(47)
. When added to suspension cultures, hyaluronidase
completely prevented cell-cell aggregation of both HCT116 and
HCTp21-/- cells (Fig. 2B)
and caused cell death in either
cell type (Fig. 2A)
. This was observed at enzyme
concentrations that were nontoxic per se, i.e.,
that neither interfered with the attachment of these cells to cell
culture plates nor their growth rate in monolayer culture (not shown;
Ref. 47
). Therefore, these results indicated that the
ability of HCT116 cells to form compact MCSs allowed them to evade cell
death.
MCS Formation of HCT Cells Is Mediated by Induction of E-Cadherin.
Cell-cell interactions by cadherins have been shown recently to
modulate survival of tumor cells under anchorage-independent conditions
(23)
. Therefore, studies were undertaken to assess
expression and function of cadherins. Using immunoblotting techniques,
a striking variance in the expression of E-cadherin in suspension
culture cells was found. In HCT116 cells, the amount of E-cadherin
protein was strongly increased when cells were transferred from
monolayer to suspension culture over a period of 48 h (Fig. 4A)
. In comparison, HCTp21-/- cells exhibited a
substantially weaker increase in E-cadherin. Two other cadherins,
P-cadherin and N-cadherin, were not detected in either cell type (not
shown), which is consistent with their preferred expression in
different groups of cells. The expression of members of the integrin
family (
v-ß3 and
v-ß5), which are cell surface proteins that
determine cell-matrix interactions, was not significantly altered in
either cell type (Fig. 4A)
. Additionally, the binding of
cells before and after suspension culture was quantitated with a
functional assay using plates coated with individual ECM proteins. No
difference in adhesion to these distinct matrices was observed between
the two cell types (Fig. 4B)
, which indicates the absence of
alterations in these types of cell-matrix interacting proteins. Thus,
these results further emphasize the specificity of differential
E-cadherin induction.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 4. Expression of E-cadherin and adhesion of cells to ECM
proteins. Cells were transferred from monolayer to suspension culture.
In A, total cell lysates were harvested at different
times thereafter and analyzed by Western blot analysis using antibodies
against E-cadherin (upper panel) and antibodies against
vß3 and vß5 integrin (VNR, lower panel). In
B, cells cultured in suspension for 24 h were
transferred into tissue culture dishes coated with different ECM
proteins. After several minutes of incubation, the dishes were
washed, and the number of adhered cells was quantitated using the MTT
assay. Each column represents the average of eight
measurements; bars, SD. In C, the
expression of p21 and E-cadherin was compared between parental HCT116
cells (+/+), HCT116 cells hemizygous for the p21 gene (+/-), and two
independent clones of HCTp21-/- cells (-/-). The cells were grown
either in monolayer (attached) or in suspension for
48 h (detached), and total cell lysates were
analyzed by Western blot analysis. Note that for E-cadherin, a longer
exposure of the immunoblot is shown to emphasize the basal levels,
which appear quite similar in all attached cells.
|
|
The observed difference in E-cadherin expression in suspension culture
was not attributable to different basal levels of this protein, because
HCT116 cells and HCTp21-/- cells grown as monolayer cultures
contained comparable amounts of E-cadherin (Fig. 4C)
.
Importantly, HCTp21+/- cells, which retained one allele of the
p21 gene, had similar basal levels of E-cadherin as well and
exhibited an induction somewhat weaker than HCT116 cells (Fig. 4C)
. In suspension, these cells formed MCSs with slightly
less density than the HCT116 cells (not shown).
To determine whether E-cadherin was indeed the crucial determinant of
the observed cell-cell interactions, HCT116 cells in suspension were
incubated with a monoclonal antihuman E-cadherin antibody (clone
SHE78-7). This antibody had been shown before to perturb the function
of E-cadherin and prevent cell-cell aggregation of tumor cells
(23)
. Indeed, when added to HCT116 cells, this antibody
completely blocked the formation of compact MCSs. The microscopic
appearance of these cells was essentially identical to the appearance
of nonantibody-treated HCTp21-/- cells as shown in Fig. 1
,
i.e., there were weakly aggregated spheroids of small size
and with individual cells clearly visible (not shown). The presence of
this antibody did not affect cell growth or morphology of these cells
in monolayer culture. As a control, an unrelated monoclonal antibody
was used. In this case, even at up to 10-fold higher concentrations, no
effects on spheroid formation were observed. Moreover, the stable
transfection of E-cadherin cDNA into HCTp21-/- cells conferred the
ability to form dense MCSs with the same morphological appearance as
those formed by HCT116 cells (Fig. 6
, Lane 4). Taken
together, these results indicate that the increased expression of
E-cadherin is the major determinant of MCS formation in these cells.
Reduction of p21 Expression in HCT116 Cells by Antisense
Oligonucleotides Reduces E-Cadherin Induction.
Because the above results demonstrated a lack of E-cadherin induction
in HCTp21-/- cells in suspension, we investigated next whether the
manipulation of p21 levels by antisense oligonucleotides would generate
a similar effect in the parental HCT116 cells. For this purpose, HCT116
cells were incubated with two different p21-antisense nucleotides that
have been shown earlier to be highly specific and effective in
inhibiting p21 expression (41)
. As a control, two
oligonucleotides were used that targeted sequences from
Mycobacterium tuberculosis. As shown in Fig. 5A
, cells treated with p21-antisense oligonucleotides
exhibited decreased E cadherin expression after cellular detachment,
whereas control oligonucleotides had no inhibitory effect. Upon
microscopic inspection, it became apparent that the cells treated with
p21-antisense oligonucleotides were unable to form compact MCSs (not
shown), and cell death was observed leading to significant differences
in cell number (Fig. 5B)
. Thus, the HCT116 cells treated
with p21-antisense oligonucleotides displayed a phenotype that was very
similar to HCTp21-/- cells.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 5. Effects of p21 antisense oligonucleotides on E-cadherin
induction and cell growth. HCT116 cells grown as a monolayer were
cultured in the presence of antisense oligonucleotides for up to
24 h and then were detached in the presence of freshly added
oligonucleotides for 24 h. AS-MID and AS-IC are two different
p21-specific antisense oligonucleotides, whereas 18 MER and 21 MER are
control oligonucleotides with the same GC content
(41)
. In A, total cell lysates were
harvested and analyzed by Western blot with anti-E-cadherin specific
antibodies. In B, cell proliferation was monitored using
the MTT assay. Shown is the average of eight measurements;
bars, SD. Dotted line, MTT staining (cell
numbers) before detachment.
|
|
Reintroduction of p21 into HCTp21-/- Cells Restores E-Cadherin
Expression.
Because the above experiments indicated that inhibition of p21 in
HCT116 cells could generate a phenotype that was similar to the
HCTp21-/- cells with respect to MCS formation and expression of
E-cadherin, we next investigated whether the reverse could be achieved
as well. Therefore, we introduced p21 cDNA into HCTp21-/- cells and
investigated whether this would restore E-cadherin induction and dense
MCS formation. HCTp21-/- cells stably transfected with an expression
vector containing p21 cDNA were generated, and 10 individual clones
were isolated and analyzed. Five of these clones exhibited increased
levels of p21 that, in four cases, correlated with increased levels of
E-cadherin and the formation of dense MCSs. One representative clone is
shown in Fig. 6
, Lane 1. The other five clones did not harbor elevated
levels of p21 and did not exhibit increased levels of E-cadherin nor
formation of dense MCSs. Thus, 80% of p21-transfected clones (four of
five) displayed elevated levels of E-cadherin and at the same time had
gained the ability to form dense MCSs. Mock-transfected cells exhibited
the same phenotype as the respective parental cells (i.e.,
no alterations), thus excluding transfection per se as the
cause of the observed alterations. Therefore, the above experiments
demonstrate a causative link between the expression of p21 and the
induction of E-cadherin in suspension cells.
Loss of p21 Potentiates Chemosensitivity in Suspension Culture.
Differences in the sensitivity toward anticancer drugs between HCT116
and HCTp21-/- cells grown as monolayer have been reported previously
(13)
. Moreover, in other tumor cells, it has been
indicated that cell-cell adhesion may affect cellular chemoresistance
as well (48)
. Therefore, to assess the impact of loss of
p21 on the chemosensitivity of detached cells, we incubated suspension
cultures of HCT116 and HCTp21-/- cells with either daunorubicin, a
clinically used anticancer drug, or with
3,6-diaziridinyl-1,4-benzoquinone (DZQ), a quinoid model
compound commonly used to study the redox-cycling abilities of
anticancer quinones (49)
. The addition of either drug to
cells immediately at the onset of suspension culture (before spheroid
formation) revealed a 2- and 2.1-fold higher chemosensitivity of
HCTp21-/- cells, which was comparable with what we observed in
monolayer culture. However, when the drugs were added 24 h after
the onset of suspension culture (when spheroids had formed), the
difference was 10- and 26.7-fold, respectively (Fig. 7)
. Therefore, in suspension culture, the differences in chemosensitivity
between these two cell types were greatly enhanced, indicating that p21
might contribute to this process via its effects on the expression of
E-cadherin and spheroid formation.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7. Chemosensitivity of cells in suspension. HCT116 cells
() and HCTp21-/- cells ( ) were treated with either daunorubicin
or with DZQ for 24 h, and cell viability was determined
thereafter with the MTT assay. On the left, the drugs
were added at the time of transfer from monolayer to suspension culture
(0 h detachment); on the right, the drugs were added
24 h after the onset of suspension culture (24 h detachment). The
IC50 ratio of HCT116 over HCTp21-/- cells is given as
R, which indicates the difference in chemosensitivity
between the two cell lines. Each point reflects the average of eight
measurements; bars, SD.
|
|
HCTp21-/- Cells Exhibit a Substantially Weakened Transformed
Phenotype.
The greatly reduced ability of HCTp21-/- cells to form MCSs suggested
that these cells might not be able to grow independently of anchorage,
and thus, that they may have lost their transformed phenotype.
Therefore, three characteristic indicators of transformed cells,
i.e., anchorage-independent growth in soft agar, focus
formation in monolayer culture, and tumor development in chicken
embryos, were analyzed. As shown in Fig. 8
, HCT116 cells were strongly positive in all of these three assays. In
contrast, HCTp21-/- were negative; they did not form foci, they
lacked the ability to grow independently of anchorage, and they formed
a >10 times smaller tumor mass in chicken embryos (Fig. 8)
. Therefore,
our results clearly indicate a correlation between the loss of the
p21 gene and a greatly reduced tumorigenic potential in
these cells.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8. Transformation-related characteristics of HCT cells.
HCT116 and HCTp21-/- cells were analyzed for different indicators of
the transformed phenotype. A, soft agar assay. Cells
(104) cells were cultured in 5 ml of soft agar, and
colonies were counted after 10 days. No colonies were apparent in
HCTp21-/- cells. B, focus formation. Cells were grown
in monolayer culture until they reached confluency. From then on, cells
were cultured for another 10 days with intermittent changes of medium.
The number of foci was counted by light microscopy. No foci were
detectable in the HCTp21-/- monolayer. C, tumor
formation on chicken chorioallantoic membrane. 106 cells/40
µl were pipetted onto the chorioallantoic membrane of 10-day-old
chicken embryos. The eggs were incubated further for 7 days.
Thereafter, the tumors were harvested, and tumor volume was determined.
HCTp21-/- developed only 9% of the average tumor volume as compared
with HCT116 cells. Bars, SD.
|
|
 |
DISCUSSION
|
|---|
The main finding of our paper is that the CKI p21 is required to
maintain the transformed phenotype of HCT116 colon carcinoma cells.
Homozygous deletion of p21 in these cells results in the loss of their
ability to form foci in monolayer culture, to grow colonies in soft
agar, and to develop tumors on chicken chorioallantoic membranes.
Furthermore, it appears that the expression of E-cadherin is intimately
involved in theses processes. Because the ability of cells to grow in
suspension (anchorage-independent growth) very closely correlates with
their tumorigenic potential (20
, 21)
, we have chosen this
aspect to further investigate the underlying differences between HCT116
cells (which harbor both copies of the p21 gene) and
HCTp21-/- cells (which were engineered to lack both copies of the
p21 gene; Ref. 37
). Both cell lines were
characterized previously and shown to exhibit identical morphology,
growth rates, and cell cycle distribution under monolayer culture
conditions (37)
.
We found, however, that upon transfer of these cells to suspension
culture conditions, obvious differences became apparent.
Microscopically, there was a striking difference in their morphological
appearance. Whereas HCT116 cells form compact, dense MCSs, HCTp21-/-
cells aggregate only very loosely (Fig. 1)
. This difference is extended
to their proliferative capacity, because HCT116 cells continue to
proliferate independently of anchorage (for at least 3 weeks in
soft agar), whereas HCTp21-/- cells cease proliferation in suspension
and die through apoptosis within 5 days. Thus, our finding was
quite surprising, because it suggested "pro-tumorigenic" functions
of the cell cycle inhibitor p21. This interpretation seems rather
contradictive, because p21 has been characterized as a major
executioner of p53-induced cell growth arrest and tumor suppression
(1
, 40
, 50
, 51)
. Interestingly, however, in contrast to
p53, which is very frequently found mutated, p21 mutations are
extremely rare in human tumors (17
, 18)
. Furthermore,
whereas p53-knockout mice develop spontaneous tumors (52
, 53)
, this phenomenon is not observed in p21-knockout mice
(11)
. Additionally, in experimental mouse skin
carcinogenesis assays, it was shown that the genetic deletion of p21
enhances the formation of papillomas but not their malignant conversion
(54)
. From these studies, it appears that the contribution
of p21 to tumorigenesis is clearly distinct from p53 and may be
restricted to early phases of neoplastic development.
Intriguingly, comparable to our results with p21, a "paradoxical
tumor inhibitory effect of p53 loss" has been described
(55)
. In this study, p53-knockout mice were crossed with
transgenic mice expressing the oncogenes v-Ha-ras,
v-fos, or transforming growth factor
targeted
to the epidermis. In keeping with the established role of p53 as a
tumor suppressor, it was anticipated that the resulting progeny would
display further increased hyperplasia and papillomatogenesis in
response to various insults such as phorbol ester treatment or
wounding. However, contrary to expectation, it was found that these
mice, now harboring the respective oncogene in the background of a
p53-negative genome, exhibited a block of spontaneous, phorbol
ester-promoted, and wound-induced hyperplasia (55)
.
Although the processes underlying these surprising effects are unclear,
it was speculated that cell type specificities, differentiation states,
or a critical combination of the synergistic neoplastic insults may
play a role. In this regard, it is interesting to note that Li-Fraumeni
individuals, who are hemizygous with respect to p53 deletions, have a
high spectrum of sarcomas, lymphomas, and breast tumors but only few
epidermal tumors (56)
. Alternatively, it was suggested
that there may be a requirement for p53 expression during the early
stages of skin tumor development, e.g., during the response
to phorbol ester-promoted or wound-induced stimuli
(55)
.
In comparison with our results and others discussed above, it could be
hypothesized that p21 may be required during later stages of tumor
development, at least in certain types of tumors, as exemplified by the
HCT116 cell line. Such a requirement of p21 could be attributable to
its documented apoptosis-inhibitory function (41
, 57, 58, 59, 60, 61)
,
which is indeed observed in the present study; when HCT cells with and
without p21 are transferred to suspension culture, HCT116 cells
continue to proliferate independently of anchorage, whereas HCTp21-/-
cells die through apoptosis (Figs. 2
and 3)
.
Our studies further demonstrate that the antiapoptotic effects of p21
during suspension culture of HCT116 cells appear to be mediated via the
induced expression of the cell surface molecule E-cadherin and closely
correlate with the ability of the cells to form dense MCSs. This is
indicated by the following observations: (a) expression of
E-cadherin is induced in HCT116 but not in HCTp21-/- cells after
detachment (Fig. 4A)
; (b) in the presence of
anti-E-cadherin antibodies, HCT116 cells loose the ability to form
dense MCSs and die through apoptosis (not shown); (c)
overexpression of transfected E-cadherin in HCTp21-/- cells results
in dense MCS formation and anchorage-independent growth (Fig. 6)
.
Together, these results indicate that MCS formation and
anchorage-independent proliferation of HCT116 cells is dependent on the
expression of E-cadherin. In this regard, our results are in agreement
with findings by others (23)
, who established that in
HSC-3 human squamous carcinoma cells, E-cadherin-mediated
intercellular adhesions were required for anchorage-independent growth
and survival of cells in suspension.
In addition, we show that the induced expression of E-cadherin is
dependent on the presence of p21: (a) E-cadherin is induced
in HCT116 but not in HCTp21-/- cells after detachment (Fig. 4A)
; (b) in HCT116 cells, inhibition of p21 by
antisense-p21 oligonucleotides results in the concurrent reduction of
E-cadherin expression during suspension culture (Fig. 5A)
;
(c) transfection of p21 cDNA into HCTp21-/- cells restores
elevated expression of E-cadherin (Fig. 6)
. Taken together, the above
observations strongly indicate that p21 regulates anchorage-independent
growth and survival via the increased expression of E-cadherin. It
should be noted that although HCTp21-/- cells do exhibit reduced
capability for DNA repair (16)
, it is unlikely that the
lack of E-cadherin regulation in these cells is attributable to
unrecognized mutations in the E-cadherin gene:
(a) we have used two different HCTp21-/- cell lines that
were selected independently of each other (37)
;
(b) the level of E-cadherin expression is the same in
HCT116, HCTp21+/-, and both HCTp21-/- cell lines during monolayer
culture (Fig. 4C)
, indicating that the basal level
regulation is intact; and (c) transfection of HCTp21-/-
with p21 cDNA restores the elevated expression of E-cadherin in
suspension culture (Fig. 6)
.
A further finding of our analysis is the greatly enhanced
chemosensitivity of HCTp21-/- cells in suspension culture.
Differential chemosensitivity of HCT116 and HCTp21-/- cells to
anticancer agents have been described before (13)
.
However, those studies used only cells grown as a monolayer. In our
present investigation, we confirm that HCTp21-/- cells are
significantly more sensitive than HCT116 cells when grown as monolayer;
however, when transferred to suspension culture, this difference is
greatly augmented, for example, from 2.1- to 26.7-fold for daunorubicin
(Fig. 7)
. Because the ability of suspension cells to form MCSs via
E-cadherin has been proposed to condition their sensitivity to
chemotherapeutic drugs (48
, 62)
, it is conceivable that
the differential expression of E-cadherin in our HCT cell model is
responsible for the observed effect. Furthermore, because we show that
elevated E-cadherin expression is dependent on the presence of p21, our
results further indicate that in suspension culture, p21 might
determine cellular chemosensitivity, at least in part, via the
expression level of E-cadherin.
The indicated involvement of p21 in the chemosensitivity of suspension
culture cells is related to results by others (63)
,
implicating another CKI, p27KIP1, in the
resistance of tumor cells to anticancer agents. Similar to our findings
with p21, it was established that the down-regulation of p27 expression
with antisense oligonucleotides in suspension culture resulted in
reduced intercellular adhesion and increased cellular sensitivity to
the drug 4-hydroperoxycyclophosphamide.
Overall, however, it appears that the exact contribution of E-cadherin
and of p21 and p27 to anchorage-independent cellular growth is strongly
dependent on the cell type under investigation. For example, E-cadherin
has been characterized as a major growth suppressor of EMT/6 mouse
mammary carcinoma cells in suspension culture (24)
,
whereas in other studies it was shown to be required for
anchorage-dependent proliferation and survival of HSC-3 human squamous
carcinoma cells (23)
. Similarly, the induction of p21 or
p27 that has been observed after transfer of cells from monolayer to
suspension culture can be detected in many but not all cell types
(22
, 33
, 35)
. It is likely that differences in the genetic
background contribute to the observed discrepancies between different
cell types. Thus, for the future analysis of these processes, it would
be helpful to comparatively investigate more cell lines where defined
genes of interest have been deleted by targeted disruption.
 |
ACKNOWLEDGMENTS
|
|---|
We thank B. Vogelstein for the HCT116 cell lines, W. El-Deiry
for p21 plasmids, B. M. Gumbiner, M. J. G. Bussemakers, and F. Van
Roy for E-cadherin clones, and P. C. Brooks and E. Petitclerc for
anti-integrin antibodies and technical assistance with the chicken
embryo tumorigenicity assays. The technical assistance of Z.
Baharians, S. Campos, and R-C. Wu is acknowledged.
 |
FOOTNOTES
|
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by Research Grant
CN-82601 from the American Cancer Society (to A. H. S.) and by Grant
1RO1HL53467 (to E. C.) and Grant R29CA74278 (to A. H. S.) from the
NIH. S. M. is a Feodor-Lynen-Fellow of the Alexander-von-Humboldt
Foundation. 
2 To whom requests for reprints should be
addressed, at Department of Molecular Microbiology and Immunology, 2011
Zonal Avenue, HMR-405, Los Angeles, CA 90033-1034. Fax:
(323) 442-1721; E-mail: schontha{at}hsc.usc.edu 
3 The abbreviations used are: CKI,
cyclin-dependent kinase inhibitor; MCS, multicellular spheroid;
poly-HEMA, poly-(2-hydroxyethyl methacrylate); MTT,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; TUNEL,
terminal deoxynucleotidyl transferase-mediated nick end labeling; ECM,
extracellular matrix; FACS, fluorescence-activated cell sorter. 
Received 5/24/99.
Accepted 10/27/99.
 |
REFERENCES
|
|---|
-
El-Deiry W. S. p21/p53, cellular growth control and genomic integrity. Curr. Topics Microbiol. Immunol., 227: 121-137, 1998.[Medline]
-
Harper J. W., Elledge S. J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev., 6: 56-64, 1996.[Medline]
-
Sherr C. J., Roberts J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.[Free Full Text]
-
Polyak K., Xia Y., Zweier J. L., Kinzler K. W., Vogelstein B. A model for p53-induced apoptosis. Nature (Lond.), 389: 300-305, 1997.[Medline]
-
Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J. P., Sedivy J. M., Kinzler K. W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (Washington DC), 282: 1497-1501, 1998.[Abstract/Free Full Text]
-
Harris C. C. p53 tumor suppressor gene: from the basic research laboratory to the clinican abridged historical perspective. Carcinogenesis (Lond.), 17: 1187-1198, 1996.[Free Full Text]
-
Waldman T., Zhang Y., Dillehay L., Yu J., Kinzler K., Vogelstein B., Williams J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med., 3: 1034-1036, 1997.[Medline]
-
Waga S., Hannon G. J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.[Medline]
-
Morgan D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1997.
-
Graña X., Reddy E. P. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11: 211-219, 1995.[Medline]
-
Deng C., Zhang P., Harper J. W., Elledge S. J., Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684, 1995.[Medline]
-
Brugarolas J., Chandraskeran C., Gordon I., Beach D., Jacks T., Hannon G. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-556, 1995.[Medline]
-
Waldman T., Lengauer C., Kinzler K. W., Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.[Medline]
-
Fan S., Chang J. K., Smith M. L., Duba D., Fornace A. J., Jr., OConnor P. M. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene, 14: 2127-2136, 1997.[Medline]
-
Li W. W., Fan J., Hochhauser D., Bertino J. R. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma- negative human sarcoma cells. Cancer Res., 57: 2193-2199, 1997.[Abstract/Free Full Text]
-
McDonald E. R., III, Wu G. S., Waldman T., El-Deiry W. S. Repair defect in p21 WAF1/CIP1-/- human cancer cells. Cancer Res., 56: 2250-2255, 1996.[Abstract/Free Full Text]
-
Kamb A. Cyclin-dependent kinase inhibitors and human cancer. Curr. Top. Microbiol. Immunol., 227: 139-148, 1998.[Medline]
-
Shiohara M., el-Deiry W. S., Wada M., Nakamaki T., Takeuchi S., Yang R., Chen D. L., Vogelstein B., Koeffler H. P. Absence of WAF1 mutations in a variety of human malignancies. Blood, 84: 3781-3784, 1994.[Abstract/Free Full Text]
-
Sutherland R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science (Washington DC), 240: 177-184, 1988.[Abstract/Free Full Text]
-
Shin S-I., Freedman V. H., Risser R., Pollack R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl. Acad. Sci. USA, 72: 4435-4439, 1975.[Abstract/Free Full Text]
-
Freedman V. H., Shin S. I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell, 3: 355-359, 1974.[Medline]
-
Kawada M., Uehara Y., Mizuno S., Yamori T., Tsuruo T. Up-regulation of p27Kip1 correlates inversely with anchorage- independent growth of human cancer cell lines. Jpn. J. Cancer Res., 89: 110-115, 1998.[Medline]
-
Kantak S. S., Kramer R. H. E-Cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J. Biol. Chem., 273: 16953-16961, 1998.[Abstract/Free Full Text]
-
St. Croix B., Sheehan C., Rak J. W., Florenes V. A., Slingerland J. M., Kerbel R. S. E-Cadherin-dependent growth suppression is mediated by the cyclin- dependent kinase inhibitor p27(KIP1). J. Cell Biol., 142: 557-571, 1998.[Abstract/Free Full Text]
-
Geiger, B., and Ayalon, O. Cadherins. Annu. Rev. Cell Biol., 8. 307332, 1992.
-
Takeichi M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol., 7: 619-627, 1995.[Medline]
-
Perl A. K., Wilgenbus P., Dahl U., Semb H., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature (Lond.), 392: 190-193, 1998.[Medline]
-
Bracke M. E., Van Roy F. M., Mareel M. M. The E-cadherin/catenin complex in invasion and metastasis. Curr. Top. Microbiol. Immunol., 213: 123-161, 1996.
-
Jankowski J. A., Bruton R., Shepherd N., Sanders D. S. Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol. Pathol., 50: 289-290, 1997.[Abstract/Free Full Text]
-
Yap A. S. The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. Cancer Investig., 16: 252-261, 1998.[Medline]
-
LaRue K. E., Bradbury E. M., Freyer J. P. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts. Cancer Res., 58: 1305-1314, 1998.[Abstract/Free Full Text]
-
Fang F., Orend G., Watanabe N., Hunter T., Ruoslahti E. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science (Washington DC), 271: 499-502, 1996.[Abstract]
-
Orend G., Hunter T., Ruoslahti E. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene, 16: 2575-2583, 1998.[Medline]
-
Kawada M., Yamagoe S., Murakami Y., Suzuki K., Mizuno S., Uehara Y. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene, 15: 629-637, 1997.[Medline]
-
Wu R-C., Schönthal A. H. Activation of p53p21waf1 pathway in response to disruption of cell-matrix interactions. J. Biol. Chem., 272: 29091-29098, 1997.[Abstract/Free Full Text]
-
Zhu X., Ohtsubo M., Bohmer R. M., Roberts J. M., Assoian R. K. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol., 133: 391-403, 1996.[Abstract/Free Full Text]
-
Waldman T., Kinzler K. W., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.[Abstract/Free Full Text]
-
Zimmer D. B., Cornwall E. H., Reynolds P. D., Donald C. M. S100A1 regulates neurite organization, tubulin levels, and proliferation in PC12 cells. J. Biol. Chem., 273: 4705-4711, 1998.[Abstract/Free Full Text]
-
Rimm D. L., Kebriaei P., Morrow J. S. Molecular cloning reveals alternative splice forms of human alpha(E)-catenin. Biochem. Biophys. Res. Commun., 203: 1691-1699, 1994.[Medline]
-
El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.[Medline]
-
Poluha W., Poluha D. K., Chang B., Crosbie N. E., Schonhoff C. M., Kilpatrick D. L., Ross A. H. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol., 16: 1335-1341, 1996.[Abstract]
-
Lewis J. G., Lin K. Y., Kothavale A., Flanagan W. M., Matteucci M. D., DePrince R. B., Mook R. A., Jr., Hendren R. W., Wagner R. W. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA, 93: 3176-3181, 1996.[Abstract/Free Full Text]
-
Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.[Abstract/Free Full Text]
-
Koopman G., Reutelingsperger C. P., Kuijten G. A., Keehnen R. M., Pals S. T., van Oers M. H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84: 1415-1420, 1994.[Abstract/Free Full Text]
-
Kim J., Yu W., Kovalski K., Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell, 94: 353-362, 1998.[Medline]
-
Chakrabarty S. Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor ß1. Int. J. Cancer, 50: 968-973, 1992.[Medline]
-
St. Croix B. S., Rak J. W., Kapitain S., Sheehan C., Graham C. H., Kerbel R. S. Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells. J. Natl. Cancer Inst., 88: 1285-1296, 1996.[Abstract/Free Full Text]
-
St. Croix B., Kerbel R. S. Cell adhesion and drug resistance in cancer. Curr. Opin. Oncol., 9: 549-556, 1997.[Medline]
-
Qiu X., Schönthal A. H., Cadenas E. Anticancer quinones induce retinoblastoma-inhibitable G2 arrest and apoptosis. Free Radical Biol. Med., 24: 848-854, 1998.[Medline]
-
Chen J., Willingham T., Shuford M., Bruce D., Rushing E., Smith Y., Nisen P. D. Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells. Oncogene, 13: 1395-1403, 1996.[Medline]
-
Eastham J. A., Hall S. J., Sehgal I., Wang J., Timme T. L., Yang G., Connell-Crowley L., Elledge S. J., Zhang W. W., Harper J. W., et al In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res., 55: 5151-5155, 1995.[Abstract/Free Full Text]
-
Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A., Jr., Butel J. S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.[Medline]
-
Jacks T., Remington L., Williams B. O., Schmitt E. M., Halachmi S., Bronson R. T., Weinberg R. A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4: 1-7, 1994.[Medline]
-
Weinberg W. C., Fernandez-Salas E., Morgan D. L., Shalizi A., Mirosh E., Stanulis E., Deng C., Hennings H., Yuspa S. H. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis. Cancer Res., 59: 2050-2054, 1999.[Abstract/Free Full Text]
-
Greenhalgh D. A., Wang X. J., Donehower L. A., Roop D. R. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor
. Cancer Res., 56: 4413-4423, 1996.[Abstract/Free Full Text]
-
Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Jr., Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A., et al Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.[Abstract/Free Full Text]
-
Zhang Y., Fujita N., Tsuruo T. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene, 18: 1131-1138, 1999.[Medline]
-
Suzuki A., Tsutomi Y., Miura M., Akahane K. Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene, 18: 1239-1244, 1999.[Medline]
-
Wang J., Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science (Washington DC), 273: 359-361, 1996.[Abstract]
-
Gorospe M., Wang X., Guyton K. Z., Holbrook N. J. Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol., 16: 6654-6660, 1996.[Abstract]
-
Gorospe M., Cirielli C., Wang X., Seth P., Capogrossi M. C., Holbrook N. J. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene, 14: 929-935, 1997.[Medline]
-
Dimanche-Boitrel M. T., Genne P., Duchamp O., Chauffert B. Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells. Cancer Lett., 85: 171-176, 1994.[Medline]
-
St. Croix B., Florenes V. A., Rak J. W., Flanagan M., Bhattacharya N., Slingerland J. M., Kerbel R. S. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat. Med., 2: 1204-1210, 1996.[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
B. Andriopoulos, S. Hegedusch, J. Mangin, H.-D. Riedel, U. Hebling, J. Wang, K. Pantopoulos, and S. Mueller
Sustained Hydrogen Peroxide Induces Iron Uptake by Transferrin Receptor-1 Independent of the Iron Regulatory Protein/Iron-responsive Element Network
J. Biol. Chem.,
July 13, 2007;
282(28):
20301 - 20308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Perrais, X. Chen, M. Perez-Moreno, and B. M. Gumbiner
E-Cadherin Homophilic Ligation Inhibits Cell Growth and Epidermal Growth Factor Receptor Signaling Independently of Other Cell Interactions
Mol. Biol. Cell,
June 1, 2007;
18(6):
2013 - 2025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-G. Kang, J. M. Jenabi, J. Zhang, N. Keshelava, H. Shimada, W. A. May, T. Ng, C. P. Reynolds, T. J. Triche, and P. H.B. Sorensen
E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase
Cancer Res.,
April 1, 2007;
67(7):
3094 - 3105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Lampugnani, F. Orsenigo, M. C. Gagliani, C. Tacchetti, and E. Dejana
Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments
J. Cell Biol.,
August 14, 2006;
174(4):
593 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. A. LaRue, M. Khalil, and J. P. Freyer
Microenvironmental Regulation of Proliferation in Multicellular Spheroids Is Mediated through Differential Expression of Cyclin-Dependent Kinase Inhibitors
Cancer Res.,
March 1, 2004;
64(5):
1621 - 1631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Matthews, C. M. Leong, L. Baxter, E. Inglis, K. Yun, B. T. Backstrom, J. Doorbar, and M. Hibma
Depletion of Langerhans Cells in Human Papillomavirus Type 16-Infected Skin Is Associated with E6-Mediated Down Regulation of E-Cadherin
J. Virol.,
August 1, 2003;
77(15):
8378 - 8385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fan, A. D. Borowsky, and R. H. Weiss
An Antisense Oligodeoxynucleotide to p21Waf1/Cip1 Causes Apoptosis in Human Breast Cancer Cells
Mol. Cancer Ther.,
August 1, 2003;
2(8):
773 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|